drugset
drugset / Trial / NCT07146672

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

NCT07146672 ↗

Phase 1/2 Recruiting 12 enrolled Shanghai Cell Therapy Group Co.,Ltd
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study is a controlled, open-label exploratory clinical trial.

Timeline

Start
2025-07-31
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Super DC Vaccine Unknown 1e+07 cells —
Subject Super DC Vaccine Unknown 2e+07 cells —

Indications

No indication recorded.